Holen Sie sich die Stockscreener-App
3.38
1.89%
-0.06
Schlusskurs vom Vortag:
$3.44
Offen:
$3.51
24-Stunden-Volumen:
3.74M
Relative Volume:
0.80
Marktkapitalisierung:
$507.50M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-3.6344
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-6.51%
1M Leistung:
-4.12%
6M Leistung:
+19.26%
1J Leistung:
+4.81%
1-Tages-Spanne:
$3.25
$3.51
1-Wochen-Bereich:
$3.25
$4.155
52-Wochen-Spanne:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Vergleichen Sie ABSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.375 | 517.28M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.17 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.41 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.40 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.73 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Will Absci Corporation stock benefit from commodity pricesJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - ulpravda.ru
What dividend safety score for Absci Corporation stockMarket Trend Review & Target Return Focused Picks - ulpravda.ru
Published on: 2026-01-08 23:53:06 - ulpravda.ru
Absci (NASDAQ:ABSI) Shares Down 9.1%Here's What Happened - MarketBeat
Morgan Stanley Downgrades Absci Corp(ABSI.US) to Hold Rating, Cuts Target Price to $4.32 - 富途牛牛
Morgan Stanley downgrades Absci stock on TL1A setback and higher risk profile - Investing.com
How resilient is Absci Corporation stock in market downturnsEarnings Miss & AI Optimized Trade Strategies - moha.gov.vn
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment - Finviz
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial - Finviz
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz
Absci (NASDAQ:ABSI) Trading Down 4.2%Here's What Happened - MarketBeat
Absci (NASDAQ:ABSI) Trading Up 11.1%Time to Buy? - MarketBeat
Why analysts remain bullish on Absci Corporation stockWeekly Profit Analysis & Smart Investment Allocation Tips - Улправда
Will Absci Corporation stock recover faster than peersMarket Risk Summary & Reliable Entry Point Alerts - Улправда
What technical charts say about Absci Corporation stock2025 Pullback Review & Weekly Chart Analysis and Trade Guides - Улправда
Is Absci Corporation stock a defensive play in 2025CPI Data & Risk Controlled Stock Pick Alerts - Улправда
Will Absci Corporation stock keep outperforming rivalsPortfolio Update Summary & Weekly Sector Rotation Insights - Улправда
ABSI Stock: HC Wainwright & Co. Raises Price Target to $8.00 | A - GuruFocus
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside - Insider Monkey
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $8 - 富途牛牛
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Will ABS-201 From Absci Transform The Future Of Hair Regeneration? - RTTNews
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Absci’s ABS-201 stimulates human hair follicle growth ex vivo - BioWorld MedTech
Independent Director of Absci Picks Up 454% More Stock - Yahoo Finance
Absci, former US soccer player Donovan announce partnership - MSN
Absci’s ABS-201 antibody shows promise for hair regrowth treatment - Investing.com
Absci’s ABS-201 antibody shows promise for hair regrowth treatment By Investing.com - Investing.com Canada
Absci Reports New Human Ex Vivo Data Demonstrating That - GlobeNewswire
Is Absci Poised for a Surge? - StocksToTrade
Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat
Absci, former U.S. soccer player Donovan announce partnership - TipRanks
Absci Corporation Partners with Landon Donovan to Address Androgenetic Alopecia and Advance Therapeutic Innovations - Quiver Quantitative
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - GlobeNewswire
Absci Corp Director Frans Van Houten Acquires 40,000 Shares - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dir Van Houten Buys 40,000 ($148.8K) Of AbSci Corp [ABSI] - TradingView — Track All Markets
Director’s Bold Move: Major Investment in AbSci Stock! - TipRanks
ABSI stock up on initiating dosing in androgenetic alopecia study - MSN
Is Absci (ABSI) Using ABS-201 To Quietly Prove The Value Of Its AI Drug Engine? - simplywall.st
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study - The Globe and Mail
Absci (NASDAQ:ABSI) Stock Price Up 10.8%Still a Buy? - MarketBeat
Absci doses first volunteers in phase 1/2a trial of hair loss antibody - Investing.com Nigeria
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pangalos Menelas N | Director |
Sep 22 '25 |
Buy |
2.66 |
95,785 |
254,788 |
113,960 |
| Bedrick Todd | SVP, CAO |
Sep 22 '25 |
Buy |
2.70 |
10,000 |
27,000 |
180,428 |
| Busch Andreas | Chief Innovation Officer |
Jul 28 '25 |
Buy |
3.04 |
50,000 |
152,000 |
327,264 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):